Science & Enterprise subscription

Follow us on Twitter

  • A new company developing treatments to relieve allergic reactions with reprogrammed antibodies began work and is ra… https://t.co/LFNVxych8d
    about 5 hours ago
  • New post on Science and Enterprise: New Allergy Biotech Launches, Raises $10M https://t.co/x5W0TwnCBu #Science #Business
    about 5 hours ago
  • Two companies and NIH are beginning a clinical trial of synthetic antibodies to both treat and prevent Covid-19 inf… https://t.co/LaUrUiRmhk
    about 24 hours ago
  • New post on Science and Enterprise: Trial Set for Covid-19 Antibodies in Long-Term Care https://t.co/tF0a7CDgGr #Science #Business
    about 24 hours ago
  • The numbers of vaccine candidates in development and clinical trials show modest but steady growth, now up to 157 a… https://t.co/AO2DxxTgF8
    about 1 day ago

Please share Science & Enterprise

Venture Funding Down in 2020, Life Sciences Stay Hot

Seed and angel investing

For the first half of 2020, venture investing declined compared to 2019, but life science and biotechnology investments continued growing for the year. . . . → Read More: Venture Funding Down in 2020, Life Sciences Stay Hot

Synthetic Protein Designed to Boost Covid-19 Vaccines

Jason McLellan and Daniel Wrapp

Researchers in Texas designed a synthetic version of a protein found on Covid-19 viruses that can make it easier to produce more vaccines. . . . → Read More: Synthetic Protein Designed to Boost Covid-19 Vaccines

Advanced Solid Tumor Precision Meds. Trial Begins

Brain tumor graphic

A clinical trial is underway testing a treatment for advanced-stage cancers that blocks amino acids allowing nutrients to feed the growth of solid tumors. . . . → Read More: Advanced Solid Tumor Precision Meds. Trial Begins

Trial Testing Point-of-Care Covid-19 Diagnostic

A clinical trial in the U.K. is assessing a testing device to detect Covid-19 viruses in nasal swab samples that returns results in an hour. . . . → Read More: Trial Testing Point-of-Care Covid-19 Diagnostic

NIH Expands Covid-19 Test Technology Challenge

Covid-19 testing

National Institutes of Health is expanding its challenge competition to make tests for Covid-19 viruses more widely available and return results faster. . . . → Read More: NIH Expands Covid-19 Test Technology Challenge

Start-Up Developing Inside-Cell Delivery, Gains $28.5M

Vesicles

A new company spun-off from Harvard University is developing techniques for delivering advanced genetic and protein therapies directly inside cells. . . . → Read More: Start-Up Developing Inside-Cell Delivery, Gains $28.5M

Tough Surgical Adhesive Commercially Licensed

Gel adhesive

A bio-materials company is acquiring the rights to develop dental sutures and membranes from an adhesive gel developed in a university lab. . . . → Read More: Tough Surgical Adhesive Commercially Licensed

Gene Therapy Production Company Opens, Raises $40M

Adeno-associated virus

A new enterprise developing and manufacturing gene therapies, both its own and for others, is underway, raising $40 million in venture funds. . . . → Read More: Gene Therapy Production Company Opens, Raises $40M

High-Capacity Brain Signal Reader Demonstrated

Brain circuits illustration

A brain-computer interface device is shown to record the highest volume of brain signals from lab animals and sheep, according to its developers. . . . → Read More: High-Capacity Brain Signal Reader Demonstrated

Oxford Covid-19 Vaccine Trial Invokes Immune Responses

Syrine ingloved hand

Results from a clinical trial testing a Covid-19 vaccine show the vaccine invokes two types of immune responses without serious adverse effects. . . . → Read More: Oxford Covid-19 Vaccine Trial Invokes Immune Responses